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Carlie S. Sigel, MD 4; Jiaqi Shi, MD5; Anjali Saqi, MD 6; Maryam Shirazi, MD6; Yue Xue, MD1; 
Olca Basturk, MD4; and Volkan Adsay, MD7
BACKGROUND: Pancreatoblastoma (PBL) is a rare malignant pancreatic tumor seen predominantly in childhood, and its 
cytologic diagnosis remains challenging. METHODS: Twelve fine-needle-aspirations from 11 adults were analyzed. RESULTS: 
In total, 6 men and 5 women (median age, 45 years; age range, 32-60 years) had tumors measuring a median 5.6 cm (range, 
2.5-12 cm) located in the pancreatic head (n = 7) or tail (n = 4), including 3 with familial adenomatous polyposis (FAP)/
FAP-related syndromes and 4 with metastasis at diagnosis. The median follow-up was 39.8 months (range, 0.8-348 months), 
and 5 patients died of disease. The original cytology diagnoses were: PBL (n = 2), neuroendocrine neoplasm (n = 2), poorly 
differentiated neuroendocrine carcinoma (n =  2), well differentiated neuroendocrine tumor (n =  1), poorly differentiated 
carcinoma (n = 2), “positive for malignancy” (n = 1), acinar cell carcinoma (n = 1), and epithelioid neoplasm with endocrine 
and acinar differentiation versus PBL (n  =  1). Universal cytopathologic findings included hypercellularity; 3-dimensional 
clusters; and single, monotonous, blast-like cells that were from 1.5 to 2.0 times the size of red blood cells with high nuclear-
to-cytoplasmic ratio, fine chromatin, small, distinct nucleoli, and a resemblance to well differentiated neuroendocrine tumor 
and poorly differentiated neuroendocrine carcinoma. Branching pseudopapillae (n = 7) and grooved nuclei (n = 3) raised 
the differential diagnosis of solid-pseudopapillary neoplasm, but with more atypia. Uncommon features included pleomor-
phism (n = 4) and numerous mitoses (n = 1). Squamoid morules were seen on smears (n = 5) or cell blocks (n = 6) in 70% 
of patients and were characterized by epithelioid cells with elongated, streaming nuclei, fine chromatin, absent nucleoli, 
and positive nuclear β-catenin (n = 6 of 8). The median Ki-67 index was 21% (range, 2%-70%), and neuroendocrine marker  
expression was common (100%), but acinar markers were variable (63%). CONCLUSIONS: A combination of cytologic find-
ings in PBL, including a predominant population of primitive blast-like cells, subtle squamoid morules, frequent neuroendo-
crine and variable acinar phenotype, should facilitate accurate cytologic diagnosis and distinction from common mimics. 
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INTRODUCTION
Although pancreatic ductal adenocarcinoma (PDAC) accounts for the vast majority of primary pancreatic 
neoplasms, other less common solid pancreatic tumors are also in the differential, particularly when tumors 
are large and circumscribed. Such differentials include neuroendocrine neoplasms (NENs) and pure or mixed 
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acinar cell carcinomas (ACCs), tumors that characteris-
tically are seen in adults. An additional consideration is 
pancreatoblastoma (PBL) an extremely rare malignant 
primary pancreatic epithelial neoplasm that accounts for 
fewer than 1% of pancreatic tumors in adults.
PBLs have historically been described under many 
names, including infantile pancreatic carcinoma and pan-
creatic carcinoma in childhood, mainly because of their 
predominance in children, in which they account for 
up to 25% of pancreatic tumors in the first decade.1-3 
Although they originally were considered pediatric tu-
mors, one-third of PBLs occur in adults.4-7 These tumors 
were first defined by Becker in 1957,8 but the term pan-
creatoblastoma was not proposed until 1975 by Kissane9 
and again by Horie et al in 1977 because of the tumor’s 
morphologic resemblance to 7-week-old fetal pancre-
atic tissue.10 Since then, there have been several reports 
describing its clinicopathologic and molecular charac-
teristics.1,5,11-13 In 1995, Klimstra et al established the 
histomorphologic features in an analysis of 14 cases—the 
largest series in the English literature.
PBL is typically a large (mean size, 10.6  cm), cir-
cumscribed, and highly aggressive tumor and shows mul-
tilineage differentiation, which is frequently acinar but 
may also be neuroendocrine, ductal, or even mesenchy-
mal. In addition, it can be distinguished from its acinar, 
neuroendocrine, and ductal counterparts by the presence 
of trademark squamoid morules, which may or may not 
be keratinized.1,5,13 Because of its rarity and polypheno-
typic nature, the diagnosis of PBL can be morphologi-
cally and immunohistochemically challenging. Although 
its histologic profile (including the entity-defining squa-
moid morules) is fairly well known, its cytologic features 
remain poorly characterized, with only isolated reports in 
the literature.14-23 Herein, we describe the cytologic find-
ings in 12 PBLs diagnosed in 11 adults and review their 
clinicopathologic characteristics, cytologic features, and 
histologic features. To the best of our knowledge, this rep-
resents the largest series in the cytology literature to date 
and the second largest in the English literature overall.
MATERIALS AND METHODS
After approval by the institutional review boards of the 
participating institutions (all primarily focused on adult 
pathology), a search of the archival pathology files was 
conducted, which yielded 12 fine-needle aspiration biop-
sies (FNABs) from 11 patients. Rapid on-site evaluation 
was performed on all cases that were deemed adequate at 
the time of evaluation. The cytology material, including 
smears, ThinPrep slides (Hologic Inc), and cell blocks, as 
well as immunostains, where available, were reviewed for 
the presence or absence of cytologic characteristics of PBL 
that were previously described in the literature, includ-
ing hypercellularity, clusters, papillae, nuclear grooves, 
nuclear molding, pleomorphism, mitotic figures, necro-
sis, squamoid morules, stromal fragments, plasmacytoid 
tumor cells, tumor cells with high nuclear-to-cytoplasmic 
ratio, fine chromatin, and small size (similar to that of 
red blood cells [RBCs]). For the purpose of this study, 
these small tumor cells with high nuclear-to-cytoplasmic 
ratios and fine chromatin were characterized as blast-like 
pancreatoblastoma cells. The presence of cytoplasmic 
microvesicles and red granules was also noted.
In addition, 10 patients had histologic material 
(resection (n = 10) plus biopsy (n = 1)) which were also 
reviewed with confirmation of the diagnosis. The pa-
tients’ clinicopathologic information was also collated.
RESULTS
Eleven patients had 12 FNABs of primary pancreatic 
masses (n = 7) and metastatic PBLs involving the liver 
(n = 4) and a mediastinal lymph node (n = 1).
Clinical Characteristics
The patients included 6 men and 5 women (male- 
to-female ratio, 1.2: 1) ranging in age from 32 to 60 years 
(median age, 45 years); 6 patients were aged <50 years 
at diagnosis, and 5 were aged <40 years at diagnosis. 
No childhood-associated tumors were identified in this 
study, possibly because of the adult-focused hospitals 
in which the contributors practice. The mean tumor 
size was 5.6  cm (range, 2.5-12  cm), 7 tumors (64%) 
were located in the pancreatic head, and 4 (36%) were 
located in the pancreatic body/tail. One patient (patient 
7) had Gardner syndrome, and 2 (patient 5 and 6) had 
familial adenomatous polyposis (FAP). Both patients 
who had FAP also had a previous history of successfully 
treated cancers (patient 5 was a woman aged 50 years 
with colonic adenocarcinoma diagnosed 14  years 
earlier, and patient 6 was a woman aged 43 years with 
small bowel adenocarcinoma who was diagnosed 1 year 
earlier and was recurrent at the time of PBL FNAB). 
In addition, we believe that patient 5 had undiagnosed 
Gardner syndrome because, in addition to FAP, she also 
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had a history of resected maxillary osteoma, colonic 
tubular adenomas, and multiple benign subcutaneous 
tumors, known features of Gardner syndrome. Three 
PBLs were metastatic at diagnosis (patients 3, 4, and 
7), and 4 metastasized years after initial diagnosis. Two 
patients developed recurrent pancreatic disease 8 years 
and 1.5 years after initial resection. Clinical character-
istics are summarized in Table 1.
Radiologic Findings
Imaging results were available for 7 of 11 patients. On im-
aging, 3 tumors were partially cystic, 2 involved the tail, 
and 1 was in the head. The biliary tree (including extra-
hepatic and intrahepatic bile ducts as well as the common 
bile duct) was dilated in 3 patients, all of them located in 
the pancreatic head. The median tumor size on imaging 
was 4.8 cm (range, 2.0-13.5 cm). Three showed evidence 
of metastasis to liver and lungs. Radiologic diagnoses in-
cluded benign (2 of 7 patients; 29%), neoplastic (2 of 7 
patients; 29%), and malignant (3 of 7 patients; 43%) dif-
ferentials. Benign differentials included 1) autoimmune 
versus chronic pancreatitis in a man aged 33  years and 
2) a pseudocyst in a patient aged 34 years. Malignant differ-
entials included 1) sarcoma/ACC versus neuroendocrine 
tumor (NET) (n = 2) and 2) serous cystadenocarcinoma 
versus serous cystadenoma (n = 1). Two cases were called 
“pancreatic neoplasm.” Patients with benign differentials 
(pseudocyst, pancreatitis, and serous cystadenoma) were 
aged <35 years, which likely influenced the benign dif-
ferential diagnoses. PBL was not raised as a differential 
in any of the patients. Radiologic diagnoses also are sum-
marized in Table 1.
Cytologic Findings
The FNAB smears were uniformly hypercellular (100%) 
with numerous 3-dimensional clusters (100%) and singly 
dispersed cells (Fig. 1). Seven cases (58%) showed branch-
ing pseudopapillae (Fig. 1) with delicate vascular cores 
akin to those seen in solid-pseudopapillary neoplasm 
(SPN), but nuclear grooves were only seen in 3 (25%) 
of them. Stromal fragments were seen in 9 cases (75%).
After reviewing all cytology samples together, a 
single-cell population with distinctive cytologic fea-
tures was identified in all samples. In all cases, these 
distinctive cells were mostly monotonous, round, blast-
like, and small (1.5-2.0 times the size of an RBC), with 
high nuclear-to-cytoplasmic ratio, scant cytoplasm, 
and infrequent (n = 4) anisonucleosis (Figs. 1‒3). This 
blast-like cell population could be distinguished from 
other primary pancreatic tumor cells that would be 
considered in the main differential diagnosis by virtue 
of having the following cytologic features: although 
similar to neuroendocrine cells of well differentiated 
NETs (WDNETs), “blast-like” cells had more cytologic 
atypia, higher nuclear-to-cytoplasmic ratio, and more 
delicate chromatin, and they lacked the coarse salt-and-
pepper chromatin of WDNETs (Fig. 1). Although, in 
areas, some tumor cells had occasional nuclear grooves 
resembling SPN (25%), the cells were more atypical 
and had larger nucleoli than SPN cells. In addition, 
blast-like cells shared some cytologic similarity with 
ACC tumor cells (Figs. 1 and 2) but lacked the mac-
ronucleoli, pleomorphism, and brisk mitotic activity 
of ACC. The blast-like cells had dark-blue cytoplasm 
on Diff-Quik stain, and some had cytoplasmic red 
TABLE 1. Clinicopathologic Characteristics of 11 Patients With Pancreatoblastoma








at Dx Follow-Up, mo
Late Mets/
Recurrence Outcome
1 33 Man   Head 2.8 Pancreatitis NA 72.2 No DOD
2 60 Man   Head 2.5 NA NA 17.9 Recurrence Alive
3 57 Man   Tail 5.0 Neoplasm Yes 3.6 No DOD
4 59 Man   Head 8.7 NA Yes 85 No DOD
5 50 Woman Gardner Head 7.5 NA No 143.7 No DOD
6 43 Woman FAP Tail 3.4 NA No 13.6 No Alive
7 34 Man Gardner Tail 2.5 Pseudocyst Yes 0.8 No DOD
8 57 Woman   Head 10.5 NET vs ACC No 6.5 No Alive
9 34 Woman   Head 12.0 SCA vs 
SCAd
No 348 Mets Alive
10 40 Man   Head 4.0 NA No 88 Mets Alive
11 32 Woman   Tail 2.5 NA No 91 Both Alive
Abbreviations: ACC, acinar cell carcinoma; DOD, died of disease; Dx, diagnosis; FAP, familial adenomatous polyposis; Mets, metastasis; NET, well differentiated 
neuroendocrine tumor; SCA, serous cystadenoma; SCAd, serous cystadenocarcinoma; NA, not available.
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granules (50%) and microvesicles (33%) (Fig. 1). On 
Papanicolaou staining, these cells consistently had high 
nuclear-to-cytoplasmic ratio; smooth nuclei; delicate, 
immature, blast-like, powdery chromatin; and distinct 
nucleoli (Figs. 1 and 2). Focal nuclear molding and 
crushing resembling small-cell carcinoma were seen in 
all cases (Figs. 1‒3). Abnormal mitotic figures were oc-
casionally seen in 5 cases but were striking (19 per 10 
high-power fields) in one (case 7)—a man aged 34 years 
with metastatic PBL who died 8 days after diagnosis. 
This case also showed more pleomorphism (Fig. 3).
Squamoid morules were seen in 9 samples (75%), on 
both smears (n = 5) and cell blocks (n = 7) (Figs. 2‒5). 
These were more readily identifiable on cell blocks 
than on smears. They were composed of whorling or 
streaming epithelioid cells with abundant, dense, gran-
ular cytoplasm; syncytial arrangement; low nuclear-to- 
cytoplasmic ratio; and elongated nuclei with blunted ends 
and vesicular chromatin (Figs. 2, 4, and 5). Morules were 
magenta-colored on Diff-Quik (Fig. 5), greenish/bluish 
on Papanicolaou, and pale pink on hematoxylin and eosin 
staining (Figs. 2, 4, and 5). Keratinization was not seen on 
alcoholic-fixed or cell block sections. One case had only 
ThinPrep slides and a cell block for review (Fig. 5A-C) 
and, although the blast-like cells were readily identifiable 
on both specimens (Fig. 5A-B), the morules were not seen 
on ThinPrep slides (Fig. 5A).
All cases were categorized as malignant/neoplastic 
on the original cytologic evaluation. The most com-
mon cytologic diagnosis was that of a “neuroendo-
crine” neoplasm (NEN) (n = 5; 42%), including NEN, 
not otherwise specified (n  =  2), poorly differentiated 
neuroendocrine carcinoma (PDNEC) (n  =  2), and 
WDNET (n = 1). Two were diagnosed as poorly dif-
ferentiated carcinoma, 1 as “positive for malignancy” 
and 1 as ACC. One case (patient 6) in which the tumor 
coexpressed neuroendocrine and acinar immunocy-
tochemical markers was initially diagnosed as mixed 
neuroendocrine and ACC versus PBL. Only 2 samples 
(17%; patients 7 and 8) were initially diagnosed as PBL, 
and squamoid morules were seen in both (on smear 
and/or cell block) and were highlighted by positive 
Figure 1. Cytologic features of pancreatoblastoma are shown, including (A) a hypercellular smear with 3-dimensional clusters of 
small, round cells (Diff-Quik stain, original magnification ×100); (B) pseudopapilla with a branching, fibrovascular core similar to that 
seen in solid-pseudopapillary neoplasm (Diff-Quik stain, original magnification ×100); (C,D) singly dispersed, monotonous, blast-
like cells with (C) high nuclear-to-cytoplasmic ratios, round nuclei, distinct nucleoli, focal plasmacytoid features, and cytoplasmic 
microvesicles (Diff-Quik stain, original magnification ×400) and (D) fine, immature chromatin and prominent nucleoli (Papanicolaou 
stain, original magnification ×400).
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nuclear β-catenin immunostaining done during initial 
workup (Fig. 3C). Two cases (patients 8 and 10) that 
were initially diagnosed as neuroendocrine neoplasms 
at outside institutions were submitted to the authors as 
consults and, based on cytomorphology and supporting 
immunoprofiling, were reclassified as PBL. The cyto-
logic findings are summarized in Table 2.
Immunocytochemical Findings on Cytologic  
Samples
Immunocytochemistry was performed on a limited num-
ber of cytology samples. Six cases stained with pancytoker-
atin (AE1/AE3) were positive. Neuroendocrine markers 
synaptophysin (n  =  10 of 10), chromogranin (n  =  6 
of 10), CD56 (n = 5 of 6) and neuron-specific enolase 
(n = 2 of 4) also were expressed by some. Trypsin was pos-
itive in 5 of 8 cases (63%), and chymotrypsin was positive 
in 1 of 2 cases (50%). Nuclear β-catenin was positive in 6 
of 8 (75%) tested cases and highlighted even subtle squa-
moid morules (Figs. 3‒5). β-Catenin immunostaining 
was performed during initial FNAB workup (n = 3 of 8 
specimens; patients 6-8) and during re-evaluation for this 
study (n = 5 of 8 specimens). The median Ki-67 prolif-
erative index in 6 tested cases was 21% (range, 2%-70%). 
For results of other immunostains, see Table 3.
Electron Microscopy Findings
Electron microscopy was performed on 1 tumor (patient 
9) that originally was diagnosed as a poorly differentiated 
carcinoma. Electron microscopy revealed cytoplasmic 
zymogen granules (a marker of acinar differentiation), 
abundant mitochondria, and prominent desmosomes, 
supporting the diagnosis of carcinoma.
Histologic Findings
Ten of 11 pancreatic tumors and 1 liver metastasis (pa-
tient 4) were resected. Tumors ranged in size from 2.5 to 
12.0 cm (median, 5.6 cm). The original histologic diag-
noses on the pancreatectomy specimens were PBL (n = 8) 
and PDNEC (n  =  2; patients 10 and 11). All showed 
Figure 2. Cytologic features of squamous morules in pancreatoblastoma are shown. (A,B) Smears reveal a 2-cell population of 
smaller, peripheral, single blast-like cells focally dissected by a squamoid morule composed of larger streaming epithelioid cells 
with pale cytoplasm, syncytial arrangement, and bland, elongated, and blunted nuclei without nucleoli (Papanicolaou stain, original 
magnification ×200). (C) A 2-cell population of small blast-like cells is present on the left, and large morular cells are seen on the 
right (Papanicolaou stain, original magnification ×400). (D) A squamoid morule composed of streaming, large epithelioid cells with 
pale cytoplasm, syncytial arrangement, and bland, elongated, blunted nuclei without nucleoli is shown (Papanicolaou stain, original 
magnification ×400).
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small, round-to-spindled, blast-like tumor cells with back-
to-back arrangement, focal rosettes, and acini (Figs. 4, 5). 
The 8 of 10 tumors that originally were called PBL also 
showed heterogeneously distributed, well demarcated, eo-
sinophilic squamoid morules, which facilitated the PBL 
diagnosis (Fig. 5). Whereas some morules were more clas-
sical in appearance, others were absent or ill-defined geo-
graphic zones, best seen after (nuclear) β-catenin staining. In 
1 case diagnosed as PDNEC (patient 11), the morules 
were pale and surrounded by rosette-like structures lined 
by columnar cells with blast-like nuclei (Fig. 4). The other 
misdiagnosed case (patient 10) showed sheets of small, 
round, blue cells in hypercellular stroma and had no defi-
nite morules (Fig. 5C). The absence and vague appear-
ance of the morules in these 2 cases likely led to PBL not 
being considered during initial workup, and both also 
were diffusely positive for AE1/AE3, synaptophysin, and 
chromogranin. The PBL diagnosis was made after me-
tastases developed (8 years after the first diagnosis), and 
the re-reviewed pancreatectomy specimens showed vague 
morules, prompting a β-catenin stain, which showed 
nuclear labeling far more than expected based on hema-
toxylin and eosin staining alone (Figs. 4, 5C).
Follow-Up Information
Follow-up information was available for all cases. The me-
dian follow-up was 72.5 months (range, 0.8-348 months). 
At last follow-up, 6 patients (55%) were alive, including 
4 with metastases or recurrence (liver metastases, n = 2; 
abdominal carcinomatosis, n = 1; pancreatic recurrence, 
n = 1), and 5 patients died of disease, 2 within 6 months 
of diagnosis.
DISCUSSION
The current study is the largest cohort to date describ-
ing the cytologic features of PBL in adults. The absence 
of pediatric cases is because the contributors practice in 
adult-focused institutions. Tumors favored the pancre-
atic head, were fairly large (median, 5.6  cm), and 45% 
of patients died of disease. Of those that were alive at last 
follow-up, the majority had recurrent or metastatic dis-
ease, with metastases most frequently to the liver. This 
Figure 3. (A) Tumor cells focally formed acini (Top Left; Diff-Quik stain, original magnification ×400) and were more pleomorphic, 
with 5-fold anisonucleolis (Bottom Left; Papanicolaou stain, original magnification ×400). (Right) Magenta-colored stroma fragments 
are also present (Diff-Quik stain, original magnification ×400). (B) A cell block shows a sheet of small, round, blue cells with high 
nuclear-to-cytoplasmic ratio (H&E stain, original magnification ×200). (C) This squamoid morule was not visible on H&E staining 
but was highlighted by nuclear β-catenin staining. Adjacent blast-like cells showed membranous and cytoplasmic β-catenin staining. 
(D) Synaptophysin showed granular cytoplasmic staining in the same case.
Original Article
714 Cancer Cytopathology  November 2019
underscores the importance of early, accurate diagnosis 
and distinction from less aggressive mimics like SPN and 
WDNET.
We found that there were 2 distinctive cytologic 
features, ie, blast-like tumor cells and squamoid mor-
ules, which corresponded to the 2-cell population cru-
cial for accurate histologic diagnosis and distinction 
from related entities with similar immunohistochemical 
profiles. Blast-like cells were small (1.5-2 times the size 
of RBCs) and had fine, immature chromatin and small 
but distinct nucleoli. Squamoid morules were seen in 
the majority of cases and were present on both smears 
and cell blocks. Morules showed a broad cytomorpho-
logic spectrum, ranging from well defined, tight clus-
ters of epithelioid cells with eosinophilic cytoplasm, 
low nuclear-to-cytoplasmic ratio, and whorled or 
streaming cytoplasm, to more ill-defined, loosely cohe-
sive, syncitial groups best seen with β-catenin staining. 
The 2-cell population of clearly malignant, blast-like 
cells juxtaposed with bland, streaming epithelioid mor-
ules was extremely helpful in correctly identifying these 
cases as PBL. Despite these features, only 2 of our cases 
were definitively diagnosed as PBL on initial FNAB, 
and 2 others were only identified when a review of the 
first 10 samples highlighted this (2-cell population) 
characteristic.
The cytologic features of PBL were first described by 
Silverman et al in 1989.21 Since then, other brief reports 
have highlighted its cytomorphology (Table 4).14-20,22-24 
In findings similar to our own, others have shown that 
PBL aspirates are typically hypercellular, with clusters and 
single, small cells that have a high nuclear-to-cytoplasmic 
ratio, round-to-oval nuclei, fine or vesicular chromatin, 
and distinct nucleoli.14-17,20-24 Pleomorphism and mitotic 
activity have only rarely been described and were occasion-
ally seen in our cohort.16,21 A second population of larger 
squamoid cells has been reported more frequently on cell 
blocks14,16,22,24 than on smears.14,15 These may contain 
biotin-rich, optically clear nuclei,14,15,23 which we looked 
for but did not see in our cohort. Other reported cyto-
logic findings in PBL include spindled cells,16,17,21,22 im-
mature mesenchyme,17,21,22 and stromal fragments,19,21 
Figure 4. This case (patient 11, sample 12) was misdiagnosed as poorly differentiated neuroendocrine carcinoma. (A) A hypercellular 
smear shows monotonous cells with a high nuclear-to-cytoplasmic ratio, powdery chromatin, and small nucleoli (Papanicolaou stain, 
original magnification ×200). (B) A cell block from the same case shows a 2-cell population of smaller, hyperchromatic, blast-like 
cells with a high nuclear-to-cytoplasmic ratio and (Inset) a subtle, squamoid morule composed of streaming epithelioid cells with 
abundant eosinophilic cytoplasm and diffuse nuclear positivity for nuclear β-catenin. A peripheral rosette is also present at the 
lower left (H&E stain, original magnification ×200). (C) A corresponding pancreatic resection, which was initially misdiagnosed as 
a neuroendocrine carcinoma, shows central, pale-pink, nuclear β-catenin–positive squamoid morules (inset) surrounded by sheets 
and gland-like groups of elongated, blast-like cells (H&E stain, original magnification ×200).
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which we recorded collectively as stromal fragments and 
saw in 75% of specimens. Branching pseudopapillae also 
were common (60%) in our cohort and, in 3 cases, also 
showed grooved, SPN-like nuclei. Pseudopapillae and 
grooved nuclei have been reported in PBL, albeit infre-
quently,14,19 and in 1 case led to misdiagnosis as SPN.19
Squamoid corpuscles (or morules, because they 
rarely have true squamous characteristics) are the en-
tity-defining hallmark of PBL. They vary in circum-
scription and number, and range from small 10-cell to 
15-cell aggregates to large, ill-defined (1.0 mm) zones,5 
which are visible on both histology and cytology sam-
ples.5,14,15,23 Morules overexpress estrogen receptor-β 
and biotin and show aberrant nuclear/cytoplasmic 
β-catenin staining, which has been exploited as a diag-
nostic marker and can highlight even the most subtle 
morules.24 The latter is because of an upregulated Wnt 
signaling pathway, which normally promotes keratini-
zation and hair folliculogenesis in utero.12,13,25,26 These 
findings suggest a shared Wnt-related pathogenesis 
(confounded by estrogen pathway alteration) in bio-
tin-rich, optically clear nuclei/morule-forming tumors 
like pulmonary blastomas, cribriform-morular papillary 
thyroid carcinoma, the complex-pyloric type of intra-
cholecystic papillary neoplasm, and even morule-form-
ing endometrial carcinomas.27 This interesting angle 
warrants further investigation. Aberrant Wnt pathway 
activation manifests as somatic CTNNB1 mutations 
(in 90% of cases) and loss of heterozygosity (LOH) of 
APC (in 10%).11 Other abnormalities include upregu-
lation of the R-spondin/LGR5/RNF43 module, a pro-
genitor-like pancreatic cell expression profile, and LOH 
of chromosome 11p.11,26 APC/β-catenin pathway alter-
ations are seen in patients with and without FAP,12,13,26 
Figure 5. (A-C) This mediastinal lymph node fine-needle aspiration (FNA) (patient 10, sample 11) was originally diagnosed as poorly 
differentiated neuroendocrine carcinoma. (A) A ThinPrep slide shows blast-like cells with distinct nucleoli and smaller, benign 
background lymphocytes (Papanicolaou stain, original magnification ×600). (B) The corresponding cell block shows a compact, 
squamoid morule highlighted by nuclear β-catenin stain (inset). (C) A corresponding pancreatic resection shows large sheets of 
monotonous, small, round-to-elongated blue cells with diffuse nuclear β-catenin staining (inset) and immature, hypercellular stroma 
(H&E stain, original magnification ×200). (D) A pancreatic FNA biopsy from case 1 that was misdiagnosed as neuroendocrine 
neoplasm shows spindled-to-oval, small, round cells with nuclear molding resembling small-cell carcinoma (Papanicolaou stain, 
original magnification ×200). (E) A 2-cell population of smaller blast-like cells is shown along with a single squamoid cell (arrow) 
with abundant, dense cytoplasm and a large nucleus (Diff-Quik stain, original magnification ×200). (F-I) Squamoid morules ranged 
from (F) ill-defined, pale-pink clusters (Diff-Quik stain, original magnification ×200) to (G) tight, whorled units of epithelioid cells 
with pale cytoplasm and syncytial arrangement (Papanicolaou stain, original magnification ×200). (H) A corresponding cell block 
and (I) pancreatic resection show similar tight, eosinophilic, squamoid morules surrounded by monotonous, blast-like blue cells with 
intervening cellular stroma (H&E stain, original magnification ×200).
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which has led some to propose that PBLs may represent 
an extracolonic manifestation of FAP.26 This is sup-
ported by the 3 patients with FAP in our small cohort. 
Another syndrome seen in childhood PBL is Beckwith-
Wiedemann syndrome, which is also associated with 
chromosome 11p LOH.28 These syndromic associations 
TABLE 2. Cytologic Features of Pancreatoblastoma in 12 Fine Needle Aspiration Biopsy Samples
Feature
Sample
%1 2 3 4 5 6 7 8 9a 10a 11 12
FNA site Pancreas Pancreas Liver Liver Pancreas Pancreas Liver Pancreas Pancreas Liver Node Pancreas  
Cellular + + + + + + + + + + + + 100
3D clusters + + + + + + + + + + + + 100
Pseudopapillae     +   + + + + +     + 58
Grooved nuclei     +           +     + 25
Blast-like cells + + + + + + + + + + + + 100
High N/C + + + + + + + + + + + + 100
Size x RBC 1.5-2.2 1.5-2.0 1.5-2.0 1.5-2.0 1.5-2.0 1.5-2.0 5-20.0 1.5-2.0 1.5-2.0 1.5-2.0 1.5-2.0 1.5-2.0  
Molding + + + + + + + + + + + + 100
Plasmacytoid             +           8
Pleomorphism + +         + +         33
Mitoses             +           8
Necrosis + +         + + + +   + 58
Vesicles +     +   + + +         42
Red granules + + + +   +           + 50
SM-smear + + +       +         + 42
SM-Cell block +         + + + +   + + 58
Stromal fragments + + +       + + + + + + 75
First cytologic Dx NEN NEC Pos NEN ACC Mixed NE-
acinar vs PBL
PBL PBL PDCA PDCA NEC NET  
First histologic Dx PBL PBL PBL PBL PBL PBL   PBL PBL NEC NEC    
Abbreviations: +, positive; ACC, acinar cell carcinoma; Dx, diagnosis; FNA, fine-needle aspiration; N/C, nuclear-to-cytoplasmic ratio; NE, neuroendocrine; NEC, 
neuroendocrine carcinoma; NEN, neuroendocrine neoplasm; NET, well differentiated neuroendocrine tumor; PBL, pancreatoblastoma; PDCA, poorly differentiated 
carcinoma; Pos, positive for malignancy; RBC, red blood cell; SM, squamoid morule.
aSamples 9 and 10 were from the same patient.
TABLE 3. Immunocytochemical Profile of Pancreatoblastoma in 12 Fine Needle Aspiration Biopsy Samples
 
Sample
1 2 3 4 5 6 7 8 9a 10a 11 12 No./Total No.
FNA Site Pancreas Pancreas Liver Liver Pancreas Pancreas Liver Pancreas Pancreas Liver Node Pancreas  
AE1/AE3 + + ND ND ND ND + ND + ND + + 6/6
Synaptophysin + + + + + + + + ND ND + + 10/10
Chromogranin + − + ND + + + − − ND + − 6/10
CD56 + ND − ND ND + + ND ND ND + + 5/6
NSE + + ND ND − ND ND ND − ND ND ND 2/4
Trypsin ND ND + ND + + + + − ND − − 5/8
Chymotrypsin         − +             1/2
β-catenin(nuclear) ND +
b − ND − + + + ND ND +b +b 6/8
LEF1 ND ND ND ND ND ND − ND ND ND + ND 1/2
Ki-67 index, % ND 50 ND ND 2 ND 70 11 ND ND 17 27  
Myo-D ND ND ND ND ND ND ND ND ND ND − ND 0/1
Myogenin ND ND ND ND ND ND ND ND ND ND − ND 0/1
Desmin ND ND ND ND ND ND ND ND ND ND − ND 0/1
CD99 ND ND ND ND ND ND ND ND ND ND − ND 0/1
CDX2 ND ND ND + ND ND ND ND ND ND ND ND 1/1
CK7 − ND ND ND ND ND ND ND ND ND ND ND 0/1
CK20 − ND ND ND ND ND ND ND ND ND ND ND 0/1
First cytologic Dx NEN NEC Pos NEN ACC Mixed NE-
acinar vs PBL
PBL PBL PDCA PDCA NEC NET  
Abbreviations: +, positive; −, negative; ACC, acinar cell carcinoma; Dx, diagnosis; FNA, fine-needle aspiration; ND, not done; NE, neuroendocrine; NEC, neu-
roendocrine carcinoma; NEN, neuroendocrine neoplasm; NET, well differentiated neuroendocrine tumor; NSE, neuron-specific enolase; PBL, pancreatoblastoma; 
PDCA, poorly differentiated carcinoma; Pos, positive for malignancy; SM, squamoid morule.
aSamples 9 and 10 were from the same patient.
bβ-Catenin staining was performed during specimen re-evaluation for study (samples 2 and 12) or for consultation (sample 11).
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emphasize not only the importance of accurate diagnosis 
of PBL on FNAB but also the need for genetic testing in 
these patients, with counselling when appropriate. The 
finding that 2 patients in our study (and others in the 
literature) had Gardner syndrome rather than ordinary 
FAP raises the question of whether PBL is more likely 
to occur in Gardner syndrome and may have a slightly 
different mechanism than ordinary FAP.
Because of its multilineage differentiation and the 
broad morphologic spectrum of the squamoid morules 
that define them, the cytohistologic diagnosis of PBL 
can be especially challenging. Squamoid morules can be 
extremely subtle or absent and were not seen in 3 of our 
cases. On the basis of location and morphology, the PBL 
differential diagnosis must include WDNET, PDNEC, 
ACC/mixed endocrine–non-neuroendocrine carcinoma, 
and SPN. Five of our cases were originally diagnosed as 
NENs, which is not surprising because they occurred in 
adults, had neuroendocrine-type morphology, and ex-
pressed neuroendocrine markers. In addition, the blast-
like cells and scattered plasmacytoid tumor cells seen in 
some of these cases resembled small-cell carcinoma and 
WDNET, respectively, and none of them were stained 
initially with β-catenin. PBL is also morphologically 
closely related to ACC, as the blast-like cells and occa-
sional acini resemble acinar cells and may express tryp-
sin or chymotrypsin. Of the 8 cases in our cohort that 
were interrogated for acinar markers (trypsin, chymo-
trypsin), 63% showed focal positivity, and 1 was misdi-
agnosed as ACC on FNAB. If the immunocytochemical 
workup is limited to a neuroendocrine or acinar panel, 
then cases can be easily misdiagnosed as NEN or ACC. 
Unless that second population of squamoid cells is iden-
tified (by light microscopy or immunocytochemistry), 
many PBLs will be missed, as happened in several of 
our cases.18,20 Because morules may be either invisible 
or indistinct zones of pallor on low-power examina-
tion, a high index of suspicion is required to ensure 
that a β-catenin stain is performed. The papillary-type 
structures, pale chromatin, and nuclear grooves seen in 
some of our cases make SPN another key cytologic dif-
ferential. Although none of our cases were misdiagnosed 
as SPN, others in the literature have been.19 The SPN 
differential poses an interesting conundrum for patholo-
gists, in that the β-catenin immunostain will not always 
allow its distinction from PBL, as the stain is positive in 
both and can also be diffuse in PBL. In addition, PBL 
may even express lymphoid enhancer-binding factor 1, 
a recently described SPN marker that was also focally pos-
itive in 1 of our cases.29 Identifying the blast-like cells 
of PBL can help with distinction as well as cytokeratin 
staining, which is positive in PBL and negative or only 
focally positive in SPN.
The PBL diagnosis is challenging not only on 
cytology but also on imaging. Large tumors often outstrip 
their blood supply and undergo cystic degeneration. As a 
result, radiologic differentials include not only solid pri-
mary pancreatic malignancies (of neuroendocrine, ductal, 
and acinar lineage) but also benign and malignant cys-
tic lesions like pseudocyst and serous cystic neoplasms. 
Interestingly, the PBL differential was not mentioned 
in any of our cases, and, in the younger patients (aged 
<35 years), even benign differentials were considered.
Conclusion
The defining cytologic characteristics of PBL, which in-
clude small, round blast-like cells and squamoid morules, 
may be subtle but are helpful in distinguishing it from other 
solid, cellular, stroma-poor pancreatic neoplasms for which 
it is often mistaken. Cytologic diagnosis often requires 
ancillary staining with multiple lineage (neuroendocrine 
and acinar) markers as well as β-catenin, which highlights 
even the most subtle squamoid morular areas. Accurate di-
agnosis is critical because of its prognostic and therapeutic 
difference from more aggressive neuroendocrine carcino-
mas and less aggressive tumors like solid-pseudopapillary 
neoplasm. Because of the strong association with ger-
mline APC mutations and FAP, a diagnosis of PBL should 
prompt genetic testing in all cases.
FUNDING SUPPORT
No specific funding was disclosed.
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
AUTHOR CONTRIBUTIONS
Michelle Reid, Volkan Adsay: Conceptualization, data curation, 
formal analysis, investigation, methodology, resources, supervision, 
and writing and editing original draft. Shristi Bhattarai, Burcin 
Pehlivanoglu: Data curation, formal analysis, investigation, meth-
odology, and project administration. Rondell Graham, Carlie 
Sigel, Jiaqi Shi, Maryam Shirazi, Yue Xue, Olca Basturk: Data 
curation, formal analysis, investigation, methodology, and review 
and editing article.
719Cancer Cytopathology  November 2019
Cytologic Diagnosis of Pancreatoblastoma/Reid et al
REFERENCES
 1. Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol. 
2007;20(suppl 1):S94-S112.
 2. Shorter NA, Glick RD, Klimstra DS, Brennan MF, Laquaglia MP. 
Malignant pancreatic tumors in childhood and adolescence: the 
Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg. 
2002;37:887-892.
 3. Ohike N, La Rosa S. Pancreatoblastoma. In: WHO Classification 
of Tumours Editorial Board, ed. WHO Classification of Tumours: 
Digestive System Tumours. 5th ed. Vol 1. IARC Press; 2019:337-339.
 4. Cavallini A, Falconi M, Bortesi L, Crippa S, Barugola G, Butturini G. 
Pancreatoblastoma in adults: a review of the literature. Pancreatology. 
2009;9(1-2):73-80.
 5. Klimstra DS, Wenig BM, Adair CF, Heffess CS. Pancreatoblastoma. A 
clinicopathologic study and review of the literature. Am J Surg Pathol. 
1995;19:1371-1389.
 6. Omiyale AO. Clinicopathological review of pancreatoblastoma in 
adults. Gland Surg. 2015;4:322-328.
 7. Zouros E, Manatakis DK, Delis SG, Agalianos C, Triantopoulou C, 
Dervenis C. Adult pancreatoblastoma: a case report and review of the 
literature. Oncol Lett. 2015;9:2293-2298.
 8. Becker WF. Pancreatoduodenectomy for carcinoma of the pancreas in 
an infant; report of a case. Ann Surg. 1957;145:864-870; discussions, 
870-862.
 9. Kissane JM. Pancreas. In: Kissane JM, ed. Pathology of Infancy and 
Childhood. 2nd ed. Mosby; 1975:320-344.
 10. Horie A, Yano Y, Kotoo Y, Miwa A. Morphogenesis of pancreatoblas-
toma, infantile carcinoma of the pancreas: report of two cases. Cancer. 
1977;39:247-254.
 11. Isobe T, Seki M, Yoshida K, et al. Integrated molecular characteri-
zation of the lethal pediatric cancer pancreatoblastoma. Cancer Res. 
2018;78:865-876.
 12. Tanaka Y, Kato K, Notohara K, et al. Significance of aberrant (cy-
toplasmic/nuclear) expression of beta-catenin in pancreatoblastoma. 
J Pathol. 2003;199:185-190.
 13. Yamaguchi S, Fujii T, Izumi Y, et al. Identification and characteriza-
tion of a novel adenomatous polyposis coli mutation in adult pancre-
atoblastoma. Oncotarget. 2018;9:10818-10827.
 14. Das S, Ghosh R, Sen A, Das RN, Saha K, Chatterjee U. Fine nee-
dle aspiration cytology diagnosis of a pancreatoblastoma in an infant: 
case report with a summary of prior published cases. Cytopathology. 
2016;27:479-482.
 15. Hasegawa Y, Ishida Y, Kato K, et al. Pancreatoblastoma. A case report 
with special emphasis on squamoid corpuscles with optically clear nu-
clei rich in biotin. Acta Cytol. 2003;47:679-684.
 16. Henke AC, Kelley CM, Jensen CS, Timmerman TG. Fine-needle as-
piration cytology of pancreatoblastoma. Diagn Cytopathol. 2001;25: 
118-121.
 17. Pitman MB, Faquin WC. The fine-needle aspiration biopsy cytology 
of pancreatoblastoma. Diagn Cytopathol. 2004;31:402-406.
 18. Rajpal S, Warren RS, Alexander M, et al. Pancreatoblastoma in an 
adult: case report and review of the literature. J Gastrointest Surg. 
2006;10:829-836.
 19. Redelman M, Cramer HM, Wu HH. Pancreatic fine-needle aspiration 
cytology in patients <35-years of age: a retrospective review of 174 
cases spanning a 17-year period. Diagn Cytopathol. 2014;42:297-301.
 20. Sigel CS, Klimstra DS. Cytomorphologic and immunophenotypical 
features of acinar cell neoplasms of the pancreas. Cancer Cytopathol. 
2013;121:459-470.
 21. Silverman JF, Holbrook CT, Pories WJ, Kodroff MB, Joshi VV. Fine 
needle aspiration cytology of pancreatoblastoma with immunocyto-
chemical and ultrastructural studies. Acta Cytol. 1990;34:632-640.
 22. Zhu LC, Sidhu GS, Cassai ND, Yang GC. Fine-needle aspiration cy-
tology of pancreatoblastoma in a young woman: report of a case and 
review of the literature. Diagn Cytopathol. 2005;33:258-262.
 23. Sahu KK, Rau AR, Bhat N, Kini JR, Mathai AM. Imprint cytology 
of pancreatoblastoma: a case report and review of the literature. Diagn 
Cytopathol. 2009;37:290-292.
 24. Nunes G, Coelho H, Patita M, et al. Pancreatoblastoma: an unusual 
diagnosis in an adult patient. Clin J Gastroenterol. 2018;11:161-166.
 25. Zhang A, Tang J, Wang S, Sun X, Ma X, Pan C. [Report of 14 cases 
with pancreatoblastoma]. Zhonghua Er Ke Za Zhi. 2016;54:47-51.
 26. Abraham SC, Wu TT, Klimstra DS, et al. Distinctive molecular 
genetic alterations in sporadic and familial adenomatous polypo-
sis-associated pancreatoblastomas: frequent alterations in the APC/
beta-catenin pathway and chromosome 11p. Am J Pathol. 2001;159: 
1619-1627.
 27. Adsay V, Jang KT, Roa JC, et al. Intracholecystic papillary-tubular 
neoplasms (ICPN) of the gallbladder (neoplastic polyps, adeno-
mas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic 
and immunohistochemical analysis of 123 cases. Am J Surg Pathol. 
2012;36:1279-1301.
 28. Kerr NJ, Chun YH, Yun K, Heathcott RW, Reeve AE, Sullivan MJ. 
Pancreatoblastoma is associated with chromosome 11p loss of het-
erozygosity and IGF2 overexpression. Med Pediatr Oncol. 2002;39: 
52-54.
 29. Singhi AD, Lilo M, Hruban RH, Cressman KL, Fuhrer K, Seethala 
RR. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) 
in solid-pseudopapillary neoplasms of the pancreas. Mod Pathol. 
2014;27:1355-1363.
